470 related articles for article (PubMed ID: 33998718)
1. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
[TBL] [Abstract][Full Text] [Related]
2. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
3. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
4. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and Antifungal Susceptibility of Infections Caused by
Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
[TBL] [Abstract][Full Text] [Related]
6. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
7. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
8. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH
Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
11. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility patterns and molecular identification of Trichosporon species.
Rodriguez-Tudela JL; Diaz-Guerra TM; Mellado E; Cano V; Tapia C; Perkins A; Gomez-Lopez A; Rodero L; Cuenca-Estrella M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4026-34. PubMed ID: 16189076
[TBL] [Abstract][Full Text] [Related]
13. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.
Taj-Aldeen SJ; Al-Ansari N; El Shafei S; Meis JF; Curfs-Breuker I; Theelen B; Boekhout T
J Clin Microbiol; 2009 Jun; 47(6):1791-9. PubMed ID: 19321719
[TBL] [Abstract][Full Text] [Related]
16. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
[TBL] [Abstract][Full Text] [Related]
17. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
18. Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole.
Sah R; Soin AS; Chawla S; Wadhwa T; Gupta N
Immun Inflamm Dis; 2019 Sep; 7(3):125-129. PubMed ID: 31006179
[TBL] [Abstract][Full Text] [Related]
19. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
20. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan.
Yang YL; Liu YW; Chen HT; Tsai MS; Chu WL; Lo HJ
Med Mycol; 2013 Nov; 51(8):880-3. PubMed ID: 23768241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
